Skip to Content



Almirall believes that partnering is key to bringing innovative medicines to patients around the world. Our partner programme is designed to add value to all participants, enriching our portfolio and extending our reach. We actively pursue new licensing opportunities in our territories. We also look for suitable partners for joint R&D projects. Our M&A seeks out prospects for company and product acquisitions. In the countries where we do not have a direct presence, we co-operate with commercially well-established local partners.